Last reviewed: May 12, 2026
Last updated: September 22, 2026
Written by: Jay Hastings, CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by: Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Director, with a PharmD and MBA specializing in pharmacogenomics and clinical product development. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies and weight-management care. Browse all Peptides & GLP-1 education
Editorial note: PlexusDx publishes this editorial review and offers one of the programs discussed. PlexusDx is not affiliated with MEDVi and has no commercial relationship with the companies named in this article; there are no affiliate links. Information is based on the sources and dates shown.
As of September 22, 2026, a new MEDVi patient choosing compounded semaglutide injection pays $179 at the first payment, then $299 per billing cycle at refill, as displayed September 22, 2026 on MEDVi's program page. That is the only MEDVi first-payment figure its public pages expose. MEDVi's ongoing month-to-month rate for compounded tirzepatide injection is $399, verified September 22, 2026, but MEDVi shows its tirzepatide first-month offer after the questionnaire; its oral tablet runs about $70 a month over its injection rate for the same compound with no tablet total published; and MEDVi offers 3-, 6- and 12-month bundles; their rates appear in its signup flow and are not published here. Any larger upfront figure must therefore be read at MEDVi's own checkout. By comparison, PlexusDx charges $0 until your provider approves the prescription, then a flat month-to-month rate such as $189/mo for Semaglutide Injection.
What is due at the first payment?
MEDVi advertises “Start for just $179, no insurance required” and says its semaglutide program starts at that price for the first month with no contract. The refill price, $299 per billing cycle as displayed September 22, 2026, applies from the second payment onward. MEDVi's page renders these figures by script, so confirm them in the official offer before you authorize a charge. MEDVi's refund policy also says consultation fees are non-refundable, so ask whether any consultation charge sits inside or outside the first payment.
The table separates the cash due at the first payment from what recurs, using only verified term details. Sources are MEDVi's program page, start.medvi.org and its cancellation and refund policy; PlexusDx figures are from its product pages.
PlexusDx publishes this comparison and offers one of the programs discussed. Information is based on the sources and dates shown.
| Plan |
Due at first payment |
Recurring charge |
Term and cancellation |
Checked |
| MEDVi compounded semaglutide injection, monthly |
$179 first month (new patients) |
$299 per billing cycle, refill / recurring, as displayed September 22, 2026 |
Cycle length not published; cancel at least 72 hours before the next billing date; no refund for the month of cancellation |
September 22, 2026 |
| MEDVi compounded tirzepatide injection |
First-month offer shown after the questionnaire; confirm in MEDVi's official offer |
$399 per billing cycle, MEDVi's ongoing month-to-month rate, verified September 22, 2026 |
Same policy as above |
September 22, 2026 |
| MEDVi multi-month plans |
3-, 6- and 12-month bundles offered; rates appear in MEDVi's signup flow and are not published here |
Not published here |
Referenced in refund policy; refundable only for months with no medication shipped |
September 22, 2026 |
| PlexusDx Semaglutide Injection, month-to-month |
$0 until provider approval, then $189 |
$189/mo |
Cancel anytime, no fees, no long-term contract |
September 22, 2026 |
| PlexusDx Semaglutide Injection, 3-month commitment |
Payment schedule shown at checkout |
$169/mo advertised rate; commitment total $507 |
3-month commitment; refund terms shown at checkout |
September 22, 2026 |
| PlexusDx Semaglutide Injection, 6-month commitment |
Payment schedule shown at checkout |
$149/mo advertised rate; commitment total $894 |
6-month commitment; refund terms shown at checkout |
September 22, 2026 |
Checked September 22, 2026. Compounded injections only; oral products and branded products are priced separately.
Compare PlexusDx plans
PlexusDx Weight Management Protocols: compounded semaglutide injection from $189/mo and tirzepatide injection from $289/mo month-to-month, all-inclusive (provider visit, prescription, medication, shipping). No membership fee. Flat price at every dose.
Compare PlexusDx plans → Start my PlexusDx intake →
Monthly equivalent is not always monthly billing
A per-month rate on a multi-month plan describes the average, not the charge. MEDVi offers 3-, 6- and 12-month bundles; their rates appear in its signup flow and are not published here, and its public pages do not show their payment timing. If MEDVi offers you a multi-month rate, ask what is charged today and whether it is one payment or several. Do not read a lower per-month figure as cancel-anytime monthly billing unless the offer says so.
The same rule applies to PlexusDx. Its 3- and 6-month tiers are advertised per-month rates on a commitment, with the commitment total shown above; the payment schedule and any refund terms for a multi-month plan are shown at checkout. Only the month-to-month plan is cancel-anytime with no fees. For the plan-type trade-offs, see MEDVi Monthly vs Prepaid Plans: Upfront Cost and Flexibility.
Financing versus total obligation
MEDVi's public pages state that HSA/FSA payment is accepted but do not describe a financing or installment provider; if one appears at checkout, treat it as a way to spread a payment, not to reduce it. Financing a multi-month plan can leave you owing the full commitment even after you stop taking the medication, because MEDVi's policy refunds multi-month plans only for months with no medication shipped and states that prescription medication cannot be returned. Before financing anything, write down the total obligation, the number of installments and what happens if you cancel mid-term. The full policy is summarized in MEDVi Subscription: Billing, Cancellation, Pauses, and Refunds.
Comparing upfront costs fairly
Compare first payments with first payments and recurring charges with recurring charges, for the same medication and route. MEDVi's $179 is a first-month rate for new patients; its $299 refill is the number to compare against another provider's month-to-month rate. A commitment tier's per-month rate belongs in a separate row against other commitment tiers, never against a competitor's month-to-month price. New-patient totals follow one formula: first payment plus (n − 1) refills. For MEDVi semaglutide injection that is $777 over 3 cycles, $1,674 over 6 and $3,468 over 12, our calculation from the displayed rates. Because MEDVi's cycle length is not published, none of those is a calendar year. Keep compounded and branded rows apart as well: compounded semaglutide is not an FDA-approved drug product and is not the same as Wegovy® or Ozempic®, as the FDA explains.
Where PlexusDx fits
If a low first payment followed by a higher refill is the part you dislike, PlexusDx removes the step: one monthly price that covers the provider visit, prescription, medication and shipping, no membership fee, flat across every dose level, and $0 charged until your provider approves. Compare PlexusDx weight-management plans, or see the broader MEDVi menu in MEDVi Cost: Semaglutide, Tirzepatide, Membership, and Plan Prices.
Questions before authorizing payment
Ask MEDVi, in writing, for the exact amount charged today and on which date the next charge posts. Ask whether the figure you were quoted is a first-month price, a refill price or a multi-month average, and how many cycles a multi-month plan covers. Ask whether the consultation fee is separate and whether the branded pathway's membership fee is billed apart from the medication. Ask how to cancel within the 72-hour notice window and what, if anything, is refunded. Prescribing decisions stay with the licensed provider in MEDVi's network; payment decisions are yours, and they are easier with those answers on paper.
A note on genetics (optional)
PlexusDx offers compounded semaglutide and tirzepatide through its Weight Management Protocols. Separately, and only if it interests you, the GLP-1 & Peptide Pathways Genetic Test ($298) analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, MC4R and TCF7L2 that relate to appetite and glucose-handling pathways. It does not predict how you will respond to any medication and does not tell you which drug, dose or provider is right for you; it is context for a conversation with your clinician. Test before you invest, and treat genetics as a guide, not a guarantee.
This article is educational. PlexusDx is not affiliated with MEDVi and has no commercial relationship with the companies discussed. PlexusDx offers compounded semaglutide and tirzepatide through its own Weight Management Protocols; this article compares approaches in the GLP-1 telehealth space. The GLP-1 & Peptide Pathways Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not predict response to any specific medication and does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol. Compounded semaglutide and tirzepatide are not FDA-approved drug products; they are prepared by state-licensed compounding pharmacies under federal compounding rules and are not the same as Wegovy®, Ozempic®, Zepbound® or Mounjaro®. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company; Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. PlexusDx is not affiliated with or endorsed by either company.
Frequently Asked Questions
How much do I pay MEDVi on day one?
For compounded semaglutide injection, a new patient pays $179 at the first payment, as advertised on MEDVi's start page. Refills are $299 per billing cycle as displayed September 22, 2026. MEDVi's ongoing month-to-month rate for compounded tirzepatide injection is $399, verified September 22, 2026, but its tirzepatide first-month offer is shown after the questionnaire, its tablet total is not published (about $70 a month over its injection rate), and its 3-, 6- and 12-month bundle rates appear only in its signup flow, so any other first-payment figure has to be read at MEDVi's own checkout.
Does a MEDVi multi-month plan bill monthly?
Unknown. MEDVi offers 3-, 6- and 12-month bundles; their rates appear in its signup flow and are not published here, and its public pages do not show their payment timing. A per-month rate on such a plan is an average, not necessarily a monthly charge. Ask what is charged today and whether it is one payment or several before you agree.
What does MEDVi refund if I cancel a multi-month plan?
MEDVi's cancellation and refund policy says multi-month plans are refundable only for months with no medication shipped, consultation fees are non-refundable, and prescription medication cannot be returned. Full refunds apply only within the first 72 hours without services received, or on medical disqualification. Read the policy on MEDVi's site before paying.
How do I compare MEDVi's upfront cost with another provider?
Match first payment to first payment and recurring rate to recurring rate for the same medication and route. MEDVi's $179 is a first-month rate for new patients; its $299 refill is the month-to-month comparison figure. Keep any commitment-tier per-month rate in a separate row, and count billing cycles rather than calendar months because MEDVi's cycle length is not published.
What does PlexusDx charge upfront?
PlexusDx charges nothing until your provider approves the prescription. After approval, the month-to-month plan bills one flat rate, such as $189/mo for Semaglutide Injection, and can be cancelled anytime with no fees. The 3- and 6-month tiers are advertised per-month rates on a commitment; their payment schedule and any refund terms are shown at checkout.
Sources and dates checked
Start my PlexusDx intake
A ~60-second intake. A licensed clinician in PlexusDx’s network reviews it and independently decides whether a prescription is appropriate. No charge unless your provider approves. Compare plans first: Compare PlexusDx plans.
Start my PlexusDx intake →
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. Sources and the dates they were checked are listed at the end of the article.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services, and offers compounded GLP-1 programs through its Weight Management Protocols. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Verify MEDVi Providers, Pharmacies, and Medication Details
How Does MEDVi Work? Intake, Prescribing, Refills, and Support